Novo yesterday presented preliminary data which showed the formulation, O1338GT, is as effective as Sanofi’s insulin injectable Lantus in controlling blood glucose levels. But the Denmark ...

and neither have on this occasion gained approval for patients who are new to injectable therapy. Sanofi may have most to lose, however, as Lantus is the biggest selling standalone long-acting ...